Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson's disease.
Tarik YongucErtuğrul SefikIpek InciÖzge Yılmaz KüsbeciSerdar CelikMehmet Erhan AydınSalih PolatPublished in: World journal of urology (2019)
OAB symptoms were significantly improved in older adults with PD under fesoterodine fumarate treatment, and this advantage continued in the open-label portion in the short term. In this randomized controlled study, the cognitive functions of the participants were not affected by fesoterodine 4 mg treatment compared with placebo.